Calling all academics, clinicians, entrepreneurs, start-ups, and industry partners who want to turn early-stage medical technologies into safe, sustainable, clinically ready devices.

The Institute for Biomedical Innovation (IBI) is a new major investment by the University of Cambridge. Based in the Department of Engineering, the IBI aims to turn early-stage medical technologies into safe, sustainable, clinically ready devices. It will combine a state-of-the-art prototyping facility equipped for microfabrication, device assembly, and biological testing, with an innovation support programme that guides researchers and companies through sustainability requirements, quality management, clinical trial design, and regulatory approval. Open to all, the IBI will provide shared laboratories, expert technical staff, and training to speed up the journey from laboratory ideas to real-world healthcare solutions, while also supporting more sustainable manufacturing and better preparedness for future health emergencies. 

Click here to complete the Institute for Biomedical Innovation Survey, before Friday the 16th of January, to help shape the next steps of development. Answers will be anonymised, combined, and used for a workshop on the final IBI mission.